Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Total Debt (2022 - 2025)

Celularity has reported Total Debt over the past 4 years, most recently at $4.3 million for Q3 2025.

  • Quarterly results put Total Debt at $4.3 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $4.3 million (changed N/A YoY), and the annual figure for FY2024 was $38.4 million, up 92.94%.
  • Total Debt for Q3 2025 was $4.3 million at Celularity, down from $40.8 million in the prior quarter.
  • Over the last five years, Total Debt for CELU hit a ceiling of $40.8 million in Q2 2025 and a floor of $4.3 million in Q3 2025.
  • Median Total Debt over the past 4 years was $34.3 million (2022), compared with a mean of $28.3 million.
  • Biggest five-year swings in Total Debt: plummeted 64.32% in 2023 and later soared 92.94% in 2024.
  • Celularity's Total Debt stood at $37.6 million in 2022, then tumbled by 47.05% to $19.9 million in 2023, then soared by 92.94% to $38.4 million in 2024, then crashed by 88.85% to $4.3 million in 2025.
  • The last three reported values for Total Debt were $4.3 million (Q3 2025), $40.8 million (Q2 2025), and $40.7 million (Q1 2025) per Business Quant data.